Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
AxoGen, Inc. (AXGN) PT Raised to $25 at Raymond James
February 25, 2025 4:00 PM ESTRaymond James analyst Jayson Bedford raised the price target on AxoGen, Inc. (NASDAQ: AXGN) to $25.00 (from $23.00) while maintaining a Outperform rating.
The analyst comments "AXGNs initial 2025 guidance was well above our expectation and the investor day preview (highlighted by an expectation of... More
AxoGen, Inc. (AXGN) PT Raised to $25 at Leerink Partners
February 25, 2025 1:07 PM ESTLeerink Partners analyst Mike Kratky raised the price target on AxoGen, Inc. (NASDAQ: AXGN) to $25.00 (from $18.00) while maintaining a Outperform rating.
The analyst comments "Bottom Line: We are reiterating our Outperform rating on AXGN and increasing our PT to $25 (from $18) following the company's 4Q24 earnings. Consistent with its preannouncement (see HERE),... More
